Cited by 148Acute Kidney Injury ResearchChronic Kidney Disease and DiabetesRenin-Angiotensin System Studies

Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney

Open access
Sato, Yuki, Mii, Akiko, Hamazaki, Yoko, Fujita, Harumi, Nakata, Hirosuke, Masuda, Kyoko, Nishiyama, Shingo, Shibuya, Shinsuke +12 more·2016·JCI Insight

Abstract

Acute kidney injury (AKI) is a common clinical condition defined as a rapid decline in kidney function. AKI is a global health burden, estimated to cause 2 million deaths annually worldwide. Unlike AKI in the young, which is reversible, AKI in the elderly often leads to end-stage renal disease, and the mechanism that prevents kidney repair in the elderly is unclear. Here we demonstrate that aged but not young mice developed multiple tertiary lymphoid tissues (TLTs) in the kidney after AKI. TLT size was associated with impaired renal function and increased expression of proinflammatory cytokines and homeostatic chemokines, indicating a possible contribution of TLTs to sustained inflammation after injury. Notably, resident fibroblasts from a single lineage diversified into p75 neurotrophin receptor + (p75NTR + ) fibroblasts and homeostatic chemokine–producing fibroblasts inside TLTs, and retinoic acid–producing fibroblasts around TLTs. Deletion of CD4 + cells as well as late administration of dexamethasone abolished TLTs and improved renal outcomes. Importantly, aged but not young human kidneys also formed TLTs that had cellular and molecular components similar to those of mouse TLTs. Therefore, the inhibition of TLT formation may offer a novel therapeutic strategy for AKI in the elderly.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.87680

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Older individuals become more susceptible to acute kidney injury and chronic kidney disease.

    “Moreover, older individuals become more susceptible to acute kidney injury (AKI) and chronic kidney disease (CKD).123,147”

    From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [147]

    The Introduction (page unavailable) says AKI incidence is increasing especially among elderly people and that older patients have worse outcomes after AKI, including progression to CKD. It supports increased AKI vulnerability and CKD risk following AKI, but not the unqualified claim that older people are more susceptible to developing CKD generally. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sato, Y., Mii, A., Hamazaki, Y., Fujita, H., Nakata, H., Masuda, K., Nishiyama, S., Shibuya, S., Haga, H., Ogawa, O., Shimizu, A., Narumiya, S., Kaisho, T., Arita, M., Yanagisawa, M., Miyasaka, M., Sharma, K., Minato, N., Kawamoto, H., & Yanagita, M.
Affiliations
  • Department of Nephrology,
  • Department of Immunology and Cell Biology,
  • Kyoto University (JP)
  • Department of Diagnostic Pathology,
  • Department of Urology,
  • Kyoto University Hospital (JP)
  • Medical Innovation Center, Graduate School of Medicine,
  • Wakayama Medical University (JP)
  • RIKEN Center for Integrative Medical Sciences (JP)
  • Howard Hughes Medical Institute (US)
  • University of Turku (FI)
  • University of California San Diego (US)
Corresponding author
Yanagita, Motoko
Venue
JCI Insight
Published
2016-07-21
Volume
1
Issue
11
Pages
e87680-e87680
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2504280359
Cited by
148
References
53
Citations by year
2026: 14 · 2025: 22 · 2024: 20 · 2023: 15 · 2022: 18 · 2021: 18 · 2020: 17 · 2019: 10 · 2018: 10 · 2017: 4
FWCI
8.05
Type
journal article
Language
en
Open access
Locations
  • JCI Insight (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by)
  • UTUPub (University of Turku) (submittedVersion)
  • Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by)
Funders
  • Boehringer Ingelheim Japan
  • Kyowa Hakko Kirin
  • Astellas Pharma
  • Mitsubishi Tanabe Pharma Corporation
  • Chugai Pharmaceutical
  • Japan Society for the Promotion of Science (15H04743, 26293106, 24111008, 24111001, 15K15151, 16K09870, 15H01154, 26220207, 25293069)
  • Daiichi Sankyo Europe
Topics
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Keywords
tertiary lymphoid tissue, acute kidney injury, aging, kidney fibroblasts, p75 neurotrophin receptor, retinoic acid, inflammatory cytokines, renal inflammation, CD4+ T cell depletion, dexamethasone, end-stage renal disease, kidney repair
MeSH terms
Adult, Age Factors, Aged, Animals, Fibroblasts, Humans, Kidney, Kidney Tubules, Lymphoid Tissue, Male, Mice, Inbred C57BL, Mice, Inbred ICR, Risk Factors, Receptors, Nerve Growth Factor, Chemokines, Mice, Acute Kidney Injury

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review